Michael A. Metzger, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 15,068 shares at $9.29 ($140K) on 2025-07-16, disclosed to the SEC on 2025-07-18.
Open-market sale of $140k SNDX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.29 | 7,534 | $70K | 50.0% |
| 2 | $9.29 | 7,534 | $70K | 50.0% |
| Total | $9.29 avg | 15,068 | $140K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |